If you have been diagnosed with low-risk prostate cancer, it is likely you know about active surveillance, a passive form of treatment that started to grow in popularity in 2010. By 2015, 42.1% of low-risk prostate cancer patients opted for getting regular PSA tests, biopsies, and imaging tests instead of a more aggressive treatment plan. […]
Watch and listen to CyberKnife patient, Shawn, and board-certified radiation oncologist and St. Louis CyberKnife Medical Director, John Bedwinek, M.D., talk about how the CyberKnife system treats cancer.
Trigeminal Neuralgia (TN) is a chronic pain disorder affecting the fifth cranial nerve. Typical TN (TN1) is characterized by attacks of intense, stabbing pain affecting the mouth, cheek, nose, and/or other areas on one side of the face. Atypical TN (TN2) is characterized by less intense, but constant dull aching or burning pain. It is […]
Our very own board-certified radiation oncologist John Bedwinek M.D. was a guest on KSDK TV’s Show Me St. Louis. Dr. Bedwinek discussed prostate cancer (risk factors, symptoms, stats) and the benefits of treating it with the CyberKnife® Robotic Radiosurgery System.
Vernon Traxler suffered from painful trigeminal neuralgia for over 16 years before he found relief with CyberKnife. Watch Vernon explain what those years felt like and how he feels now after being treated at St. Louis CyberKnife.
Watch Yu Sharon Chen, M.D., a board-certified radiation oncologist with St. Louis CyberKnife, discuss the CyberKnife® Robotic Radiosurgery System (what it is, how it works, what it treats, benefits of treatment, etc.) on KSDK’s Show Me St. Louis.
Our very own board-certified radiation oncologist John Bedwinek M.D. was a guest on KSDK TV’s Show Me St. Louis. Dr. Bedwinek discussed prostate cancer (risk factors, symptoms, stats) and the benefits of treating it with the CyberKnife® Robotic Radiosurgery System.
David Morris, M.D., Radiation Oncologist and Medical Director at St. Louis CyberKnife, was a guest on Great Day Saint Louis. Watch Dr. Morris discuss prostate cancer (risk factors, signs and symptoms, current stats, etc.) and the benefits of treating it with CyberKnife technology.
Accuray Incorporated, developer and manufacturer of the CyberKnife® System, announced that published data from two multicenter studies using differing protocols provide consistent results and reinforce the use of the CyberKnife system for the effective management of low-and intermediate-risk prostate cancer. The studies are the largest conducted to date evaluating stereotactic body radiation therapy (SBRT) in […]